Liquid Biopsy Market offers good growth opportunities during the next five-year period ending 2028. In its detailed market assessment report, Stratview Research has analyzed the Liquid Biopsy Market’s emerging trends, forecasts, competitive landscapes, and factors governing the market dynamics.
Global Liquid Biopsy Market Forecast:
The liquid biopsy market was estimated at USD 2.4 billion in 2021 and is expected to grow at a CAGR of 18% during 2022-2028 to reach USD 7.64 billion in 2028.
The study will cover market intelligence and information for a period of 12 years from 2016 to 2028. The base year for the study is 2021.
What is Liquid Biopsy?
Liquid biopsy, also known as fluid biopsy or fluid phase biopsy, is the sampling and analysis of non-solid biological tissue, mainly blood. This technique is mainly used as a diagnostic and monitoring tool for diseases such as cancer, with the added benefit of being largely non-invasive.
Liquid Biopsy COVID Impact.
The impact of the global pandemic Covid-19 was felt across all industries in every field. However, the liquid biopsy market managed to escape the pandemic with minimum damage. The liquid biopsy market witnessed a slight decline in the year 2020 during the pandemic and is likely to rebound at a healthy rate in the forecast period.
The Liquid Biopsy Market growth depends upon numerous factors which have direct or indirect impact the demand.
The key factors governing the demand for Liquid Biopsy Market are:
- Market structure: Overview, industry life cycle analysis, supply chain analysis
- Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
- Market trend and forecast analysis
- Market segment trend and forecast
- Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
- Attractive market segments and associated growth opportunities
- Emerging trends
- Strategic growth opportunities for the existing and new players
- Key success factors
Market Drivers
The growth of the liquid biopsy market is primarily driven by:
- Increase in the number of cancer patients,
- Increasing demand for non-invasive treatment procedures,
- Growing awareness about the benefits of liquid biopsy,
- Advantages such as low cost, rapid and accurate results, and early detection of diseases.
About Stratview Research
Stratview Research is a global market intelligence firm providing wide range of services including syndicated market reports, custom research, and sourcing intelligence across industries, such as Advanced Materials, Aerospace Defense, Automotive Mass Transportation, Consumer Goods, Construction Equipment, Electronics and Semiconductors, Energy Utility, Healthcare Life Sciences, and Oil Gas.
We have a strong team of industry veterans and analysts with an extensive experience in executing custom research projects for mid-sized to Fortune 500 companies, in the areas of Market Assessment, Opportunity Screening, Competitive Intelligence, Due Diligence, Target Screening, Market Entry Strategy, Go to Market Strategy, and Voice of Customer studies.
Stratview Research is a trusted brand globally, providing high quality research and strategic insights that help companies worldwide in effective decision making.
